Loading...
NPI 1457977209 · Houston, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Genview Diagnosis Inc is a clinical medical laboratory provider located in Houston, Texas. This profile covers 68 Medicare and 122 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Genview Diagnosis Inc |
| Address | 5252 Hollister St Ste 520 |
| City | Houston |
| State | TX |
| ZIP | 77040 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 17, 2020 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $8.9M |
| Medicare | $1.1M |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
68 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 5,510 | $30 | $187.3K |
| 81185 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the calcium voltage–gated channel subunit alpha1 A gene, also called CACNA1A. | 110 | $830 | $94.5K |
| 81302 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the methyl CpG binding protein 2, or MECP2 gene. | 130 | $520 | $64.6K |
| 81325 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the peripheral myelin protein 22, or PMP22, gene. | 80 | $750 | $60.3K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 1,520 | $30 | $51.7K |
| 81249 | The lab analyst performs the technical lab test to analyze known the full gene sequence of the glucose–6–phosphate dehydrogenase (G6PD) gene. | 70 | $590 | $39.4K |
| 81307 | The lab analyst performs the technical lab test on a specimen such as blood, to analyze the entire gene sequence for the partner and localizer of BRCA2 (PALB2) gene. | 50 | $660 | $35.1K |
| 81238 | The lab analyst performs the technical lab test to analyze the full gene sequence of the coagulation factor IX (F9) gene. | 50 | $590 | $30K |
| 81189 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the cystatin B gene (CSTB). | 110 | $270 | $29.9K |
| 81309 | The lab analyst performs the technical lab test to analyze specific gene sequences of the phosphatidylinositol–4, 5–biphosphate 3–kinase, catalytic subunit alpha (PIK3CA) gene. | 110 | $270 | $29.9K |
Showing 1–10 of 68
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 68 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
68 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81185 | 5 | 10 | 110 | $820 | $906.1K |
| 81325 | 5 | 10 | 90 | $750 | $582.2K |
| 81302 | 4 | 10 | 90 | $520 | $479.9K |
| 81317 | 13 | 20 | 220 | $660 | $382.7K |
| 81298 | 13 | 20 | 220 | $630 | $362.7K |
| 81307 | 13 | 20 | 150 | $660 | $361.4K |
| 81249 | 16 | 20 | 80 | $590 | $319.2K |
| 81238 | 13 | 20 | 110 | $590 | $281.7K |
| 81309 | 5 | 10 | 110 | $270 | $278.9K |
| 81189 | 5 | 10 | 110 | $270 | $278.2K |
Showing 1–10 of 68
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
122 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 16,270 | $140 | $2.3M |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 14,750 | $30 | $412.9K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 9,320 | $40 | $391.5K |
| 81162 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the BRCA1, DNA repair–associated gene, also called BRCA1; and BRCA2, DNA repair–associated gene, also called… | 250 | $1,180 | $293.3K |
| 81185 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the calcium voltage–gated channel subunit alpha1 A gene, also called CACNA1A. | 550 | $490 | $271.5K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2,000 | $110 | $221.4K |
| 81302 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the methyl CpG binding protein 2, or MECP2 gene. | 630 | $340 | $214.7K |
| 87556 | The lab analyst performs a test for Mycobacterium tuberculosis using amplified nucleic acid probe technique. Mycobacteria tuberculosis are sometimes called acid fast bacteria because of the special… | 13,770 | $20 | $206.6K |
| 81307 | The lab analyst performs the technical lab test on a specimen such as blood, to analyze the entire gene sequence for the partner and localizer of BRCA2 (PALB2) gene. | 400 | $430 | $172.3K |
| 87496 | The lab analyst performs a test for cytomegalovirus, or CMV, using amplified nucleic acid probe technique. CMV may cause severe illness in newborns and immunocompromised patients. | 14,330 | $10 | $171.9K |
Showing 1–10 of 122
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
122 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 80 | 340 | 400 | $50 | $553.5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 73 | 100 | 470 | $50 | $319.1K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 69 | 150 | 170 | $30 | $302.9K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 12 | 240 | 420 | $30 | $296.8K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 42 | 290 | 410 | $20 | $225K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 19 | 300 | 410 | $20 | $223.4K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 4 | 140 | 180 | $60 | $215.9K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 31 | 150 | 320 | $20 | $184K |
| 81329 | The lab analyst performs the technical lab test to detect deletions in the survival of motor neuron 1 (SMN1), telomeric, gene and may also analyze the survival of motor neuron 2 (SMN2), centromeric,… | 6 | 20 | 70 | $40 | $178.1K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 24 | 100 | 650 | $50 | $161.3K |
Showing 1–10 of 122
Other providers in the same ZIP code as Genview Diagnosis Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Laboratory Corporation Of America | TX | Clinical Medical Laboratory | $27.2M | $103.8M |
| Rapid Dx Laboratory LLC | TX | Clinical Medical Laboratory | $4.8M | $927.8K |
| Jason Baron | TX | Psychiatry Physician | $127.6K | $0 |
| Mirlene Appolon | TX | Family Nurse Practitioner | $117.2K | $6.4K |
| Babatunde Otinwa | TX | Emergency Medicine Physician | $116.3K | $0 |
| Nowice Trexler | TX | Diagnostic Radiology Physician | $83.8K | $0 |
| Adam Alli | TX | Vascular & Interventional Radiology Physician | $81.2K | $0 |
| Jaideep Barge | TX | Diagnostic Radiology Physician | $40.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.